The drug release of well-established local drug delivery (LDD) systems is either diffusion or chemically controlled. However, drugs are released independently of their need, possibly leading to ineffectiveness of the LDD systems at the time of interest. Novel intelligent systems hence foresee an appropriate drug release at an adequate time, exemplarily established by a hydrogel-coating whose swelling property and drug permeability is dictated by the presence of a specific protein. In this context, we systematically investigated the drug permeation though various polyacrylamide-gels as model coating. In order to define this design at the example of polyacrylamide we initially investigated the effect of the monomer-to-crosslinker-ratio (acrylamide (AAm)/N,N´-methylenebisacrylamide (MBAA)) and the gel content on the temporal release of model drugs, such as albumin and myoglobin in a chamber especially designed for these test runs. Among performed experiments, the gel content evidenced the strongest effect on drug permeation. For instance, several test runs using different AAm/MBAA-ratios showed comparable drug permeation, while they all illustrated increasing drug permeability with decreasing gel-content. High gel content seems to be hence afforded for the formation of a stable, impermeable implant coating, whereas the amount of MBAA as crosslinker could be reduced in favor of sensor molecules. The realized studies give evidence of the afforded gel composition, which is a high general content and a low grade of crosslinking to allow integration of sensor molecules, aiming at stimulus-induced LDD systems.
Introduction
The optimal interaction of implant surfaces with the surrounded tissue plays an important role in the modern regenerative medicine. With the purpose to optimize the implant-cell/tissue interaction a lot of surface modification strategies were investigated and established in the last 10 years. Today, many implants, such as stents, are equipped with drug-containing polymeric coatings in order to obtain local drug delivery (LDD) systems with controlled and sustained rates of drug release [1, 2] . Besides the benefit that the drug is fixed on the implant's surface and relatively protected against mechanical stress, a polymeric coating allows a wide range of control over the release characteristics of the drug. These LDD systems are preferred diffusion-controlled systems. Furthermore, chemicallycontrolled LDD systems are under consideration, which allow the immobilization of biomolecules, such as growth factors, antibodies and RGD peptides. For chemically controlled, stimulus-responsive LDD systems on the basis of hydrogels the stimulus can be caused by changes of pH and temperature as well as by electric fields [3, 4] . These stimuli leads mostly to structural changes of the hydrogel and in this context to a hydrogel swelling. Another example of stimulus-responsive LDD systems are enzymecontrolled hydrogels based on glucose oxidase. The enzyme causes the oxidation of glucose and therefore a decrease of pH which leads to a swelling of the hydrogel and the release of the embedded insulin [5] . With this conception an indirect hydrogel response to the glucose oxidation under release of a drug can be realized. Following these investigations the purpose of our study is the development of a stimulus-responsive LDD system which allows the direct hydrogel response triggered by a stimulus localized in the surrounded tissue. The principle of our stimulus-responsive LDD system is illustrated in Image 1.
Image 1
Principle of the stimulusresponsive LDD system. Without any external stimulus localized in the surrounded tissue no hydrogel change takes place (1) . Only in presence of a stimulus in form of specific biomolecules which bind at the hydrogel structure (2), the hydrogel starts to swell (3) and releases the drug (4).
Methods
A polyacrylamide-based hydrogel was chosen. First tests, being in progress, targeted on the investigation of permeability of two model proteins by means of hydrogels with different ratios (w/w) of acrylic acid amide (AAm) and N,N´-methylenebisacrylamide (MBAA) and different AAm/MBAA contents (w %). These factors seem to be important for the permeation characteristic of drugs due to their influence on mesh size, like shown in Image 2. These investigations were performed to find the optimal state of the gel where not the drug permeated without any barrier function, but rather the drug started to permeate.
Image 2
Influence of AAm/MBAA ratio and gel content on the mesh size.
Experimental

Materials
As model biomolecules the different-sized proteins albumin (66 kDa) (bovine serum albumin, BSA, Serva, Germany) myoglobin (17 kDa) (from equine heart, SigmaAldrich, Germany) were used. The preparation of polyacrylamide gels was performed with AAm (99+%, SigmaAldrich), MBAA (99%, Sigma-Aldrich), N,N,N´,N´-tetramethylethylenediamine (TEMED, Sigma-Aldrich), ammonium persulfate (APS, 99.99+%, Sigma), ultra-pure water (deionized with arium 611 DI/611UV, Sartorius Stedim Biotech, Germany) and, for washing of the gels and as medium for protein-liberation, Dulbecco´s phosphate buffered saline (DPBS, without Ca and Mg, PAA, Austria). The measurement of permeated protein takes place after treatment with Pierce ® BCA Protein Assay Kit (Thermo Scientific, USA) at a wavelength of 560 nm with a Fluostar Optima (BMG Labtech, Germany).
Gel preparation
Started with a 30% 29/1 (AAm/MBAA) and a 30% 58/1 solution of AAm and MBAA in ultra-pure water, these solutions were diluted in several manners for the 117/1 and the 235/1 ratio (Table 1.).
Table 1
Overview of the prepared polyacrylamide-based hydrogels. For the preparation of Ø=25 mm gels 300 µl consisting of the following components were used: 30% 29/1 (AAm/MBAA), 30% 58/1 (AAm/MBAA), 30% (AAm) and ultra-pure water.
After mixing the named volumes, 30 µl of a 0.1 molar APS solution in ultra-pure water and a 0.8 molar solution of TEMED in ultra-pure water were added for starting the reaction (Image 3). 330 µl of this solution were pipetted between two glasses of a diameter of 25 mm. After 20 minutes the prepared gels were transferred into a PBSbuffer for 1 h to delete residual monomers.
Image 3 Scheme of the polymerization of AAm with MBAA by means of APS and TEMED.
For the investigation of the permeation behavior of the used proteins in a test chamber (Image 4) swollen gel samples were blanked out from the whole gel film and were put on glasses with a defined amount of protein. The gel samples were covered with 500 µl PBS. After 24 h, 48 h and 72 h 400 µl of the buffer were removed and replaced by fresh PBS. Then the removed PBS was analyzed regarding the penetrated protein by means of a BCA assay.
Image 4
Test chamber: Model of the chamber (left) and photograph of the chamber with gel samples in front (right).
Permeation measurement
For quantifying the released protein concentration 25 µl of the PBS/protein mixture were combined with 200 µl BCA reagent. After incubating for 30 min at 37°C the absorption was measured at 560 nm. Only proteins with reductive groups and specific macromolecular structures caused, under alkaline conditions, a reduction of Cu² + to Cu + (Biuret reaction). The bicinchoninic acid forms a purple-colored complex with the Cu + -ion (Image 5), which is measured photometrical.
Image 5
Formation of the complex by copper and two bicinchoninic acid molecules.
Results
The results of the performed experiments indicate that the gel content has a strong effect on protein permeation. Images 6 and 7 demonstrate an increase in permeability due to decreased gel content. It indicates that the effect of content is of higher importance than the AAm/MBAA ratio in the smaller ranges.
Image 6 Albumin release in percent after 1 day compared to a maximum release of measured 332 µg (100 %): gel ratio AAm/MBAA 29/1; gel content 7.5, 15, 30 % For example, several test series using different AAm/MBAA ratios showed comparable drug permeation, in which they illustrated increasing drug permeability with decreasing gel content.
Image 7 Albumin release in percent after 1 day compared to a maximum release of measured 247 µg (100 %): gel ratio AAm/MBAA 58/1; gel content 7.5, 15, 30 %.
However, high gel contents seems to be suitable for the formation of a stable and impermeable implant coating, whereas the amount of MBAA as crosslinker could be reduced for the implement of sensor molecules. Preliminary test series performed with myoglobin showed the same results (Image 8).
Image 8 Myoglobin release in percent after 1 day compared to a maximum release of measured 264 µg (100 %): gel ratio AAm/MBAA 58/1; gel content 7.5, 15, 30 %.
Conclusion
The performed studies give an indication about the required gel composition. The gel should contain a high total content of polymer and a low degree of crosslinking to facilitate the integration of sensor molecules which are necessary to target the stimulus induced LDD system in the subsequent step.
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